Medecine sciences : M/S, 05/2017, Volume 33, Issue 5, p. 469
Journal Article
Medecine/Sciences, ISSN 0767-0974, 05/2017, Volume 33, Issue 5, pp. 469 - 473
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 2009, Volume 5, Issue 214, pp. 1663 - 1667
Journal Article
Pathology, ISSN 0031-3025, 11/2019
Journal Article
5.
Full Text
Breast implant‐associated anaplastic large cell lymphoma and other rare T‐cell lymphomas
Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue 1, pp. 24 - 29
ONCOLOGY | HEMATOLOGY | FEATURES | Lymphoma, Large-Cell, Anaplastic - epidemiology | Breast Implants - adverse effects | Humans | Female | Lymphoma, Large-Cell, Anaplastic - pathology | Lymphoma, Large-Cell, Anaplastic - etiology | Lymphoma, Large-Cell, Anaplastic - metabolism | Lymphomas | T cells | Implants, Artificial | Prosthesis | Lymphoma | Anaplastic large-cell lymphoma
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2015, Volume 21, Issue 17 Supplement, pp. IA02 - IA02
Journal Article
Virchows Archiv, ISSN 0945-6317, 11/2018, Volume 473, Issue 5, pp. 655 - 656
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 3/2019, Volume 68, Issue 3, pp. 467 - 478
The tumor-expressed CD73 ectonucleotidase generates immune tolerance and promotes invasiveness via adenosine production from degradation of AMP. While...
Immunohistochemistry | CD73 | Immunology | Pancreatic carcinoma | Medicine & Public Health | Oncology | Cancer Research | Hepatocellular carcinoma | Ecto-5′-nucleotidase | Cholangiocarcinoma | TARGET | CANCER CELLS | Ecto-5 '-nucleotidase | ADENOSINE | IMMUNOLOGY | OVEREXPRESSION | MELANOMA | PROGNOSTIC BIOMARKER | ONCOLOGY | IMMUNOTHERAPY | GROWTH | CD39 | DIFFERENTIATION | 5'-Nucleotidase - antagonists & inhibitors | Carcinoma, Hepatocellular - mortality | Pancreatic Neoplasms - chemistry | Prognosis | Humans | Liver Neoplasms - chemistry | Liver Neoplasms - mortality | Biliary Tract - chemistry | Bile Duct Neoplasms - chemistry | Epithelial-Mesenchymal Transition | Carcinoma, Pancreatic Ductal - mortality | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - chemistry | Pancreatic Neoplasms - mortality | GPI-Linked Proteins - antagonists & inhibitors | GPI-Linked Proteins - analysis | Pancreatic Neoplasms - pathology | Cholangiocarcinoma - mortality | 5'-Nucleotidase - analysis | Carcinoma, Pancreatic Ductal - pathology | Liver - chemistry | Carcinoma, Pancreatic Ductal - chemistry | Cholangiocarcinoma - pathology | Cholangiocarcinoma - chemistry | Bile Duct Neoplasms - mortality | Carcinoma, Hepatocellular - pathology | Bile Duct Neoplasms - pathology | Pancreas - chemistry | Liver cancer | Adenylic acid | Immunotherapy | Pancreatic cancer | Nucleotidases | Adenocarcinoma | Biliary tract | Adenosine | Carcinoma | AMP | Tumor cells | Invasiveness | Immunological tolerance | Patients | E-cadherin | Hepatocytes | CD73 antigen | Ectonucleotidase | Pancreas | Tumors
Immunohistochemistry | CD73 | Immunology | Pancreatic carcinoma | Medicine & Public Health | Oncology | Cancer Research | Hepatocellular carcinoma | Ecto-5′-nucleotidase | Cholangiocarcinoma | TARGET | CANCER CELLS | Ecto-5 '-nucleotidase | ADENOSINE | IMMUNOLOGY | OVEREXPRESSION | MELANOMA | PROGNOSTIC BIOMARKER | ONCOLOGY | IMMUNOTHERAPY | GROWTH | CD39 | DIFFERENTIATION | 5'-Nucleotidase - antagonists & inhibitors | Carcinoma, Hepatocellular - mortality | Pancreatic Neoplasms - chemistry | Prognosis | Humans | Liver Neoplasms - chemistry | Liver Neoplasms - mortality | Biliary Tract - chemistry | Bile Duct Neoplasms - chemistry | Epithelial-Mesenchymal Transition | Carcinoma, Pancreatic Ductal - mortality | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - chemistry | Pancreatic Neoplasms - mortality | GPI-Linked Proteins - antagonists & inhibitors | GPI-Linked Proteins - analysis | Pancreatic Neoplasms - pathology | Cholangiocarcinoma - mortality | 5'-Nucleotidase - analysis | Carcinoma, Pancreatic Ductal - pathology | Liver - chemistry | Carcinoma, Pancreatic Ductal - chemistry | Cholangiocarcinoma - pathology | Cholangiocarcinoma - chemistry | Bile Duct Neoplasms - mortality | Carcinoma, Hepatocellular - pathology | Bile Duct Neoplasms - pathology | Pancreas - chemistry | Liver cancer | Adenylic acid | Immunotherapy | Pancreatic cancer | Nucleotidases | Adenocarcinoma | Biliary tract | Adenosine | Carcinoma | AMP | Tumor cells | Invasiveness | Immunological tolerance | Patients | E-cadherin | Hepatocytes | CD73 antigen | Ectonucleotidase | Pancreas | Tumors
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2018, Volume 18, pp. S95 - S96
Journal Article
Virchows Archiv, ISSN 0945-6317, 9/2019, Volume 475, Issue 3, pp. 313 - 323
Breast cancer is a highly heterogeneous disease. The efficacy of tailored therapeutic strategies relies on the precise detection of diagnostic biomarkers by...
Immunohistochemistry | Pathology | Breast cancer | Medicine & Public Health | Microfluidic tissue processor | PATHOLOGY | Epidermal growth factor | Oncology, Experimental | Clinical trials | Diagnosis | Research | Comparative analysis | Microfluidics | Formaldehyde | Cancer | Paraffins | Antigens | Automation | Estrogens | Estrogen receptors | Staining | Paraffin | Medical diagnosis | ErbB-2 protein | Breast carcinoma | Gene amplification | Biomarkers | Breast | Diagnostic systems | Progesterone | Growth factors
Immunohistochemistry | Pathology | Breast cancer | Medicine & Public Health | Microfluidic tissue processor | PATHOLOGY | Epidermal growth factor | Oncology, Experimental | Clinical trials | Diagnosis | Research | Comparative analysis | Microfluidics | Formaldehyde | Cancer | Paraffins | Antigens | Automation | Estrogens | Estrogen receptors | Staining | Paraffin | Medical diagnosis | ErbB-2 protein | Breast carcinoma | Gene amplification | Biomarkers | Breast | Diagnostic systems | Progesterone | Growth factors
Journal Article
International Journal of Surgical Pathology, ISSN 1066-8969, 6/2019, Volume 27, Issue 4, pp. 399 - 400
Journal Article
Seminars in Hematology, ISSN 0037-1963, 01/2014, Volume 51, Issue 1, pp. 5 - 16
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 02/2015, Volume 11, Issue 461, pp. 411 - 417
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S106 - S108
Journal Article
Annals of Hematology, ISSN 0939-5555, 6/2019, Volume 98, Issue 6, pp. 1513 - 1516
Medicine & Public Health | Hematology | Oncology | CHRONIC INFLAMMATION | HEMATOLOGY | NF-KAPPA-B | Non-alcoholic Fatty Liver Disease - pathology | Frameshift Mutation | Liver Neoplasms - genetics | Gastritis - complications | Humans | Liver Neoplasms - complications | Helicobacter Infections - complications | Male | Inflammation | Metabolic Syndrome - complications | Lymphoma, B-Cell, Marginal Zone - genetics | CREB-Binding Protein - genetics | Non-alcoholic Fatty Liver Disease - complications | Point Mutation | Tumor Necrosis Factor alpha-Induced Protein 3 - genetics | Lymphoma, B-Cell, Marginal Zone - complications | Aged | Helicobacter pylori - isolation & purification | Causality | Neoplasm Proteins - genetics | Lymphomas
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 01/2019, Volume 43, Issue 1, pp. 110 - 120
Primary mediastinal large B-cell lymphoma (PMBL) is a mature large B-cell lymphoma of putative thymic B-cell origin involving the mediastinum with younger age...
cyclin D1 | primary mediastinal large B-cell lymphoma | reverse transcriptase-multiplex ligation-dependent probe amplification (RT-MLPA) | mutational analysis | nonmediastinal | MOLECULAR CHARACTERIZATION | SURGERY | CD30 EXPRESSION | D1 EXPRESSION | DIAGNOSIS | TUMOR-SUPPRESSOR GENE | PATHOLOGY | FEATURES | RECURRENT | MYC | HODGKIN LYMPHOMA | MUTATIONS | Genetic aspects | Research | Non-Hodgkin's lymphomas | Gene expression | Copy number variations
cyclin D1 | primary mediastinal large B-cell lymphoma | reverse transcriptase-multiplex ligation-dependent probe amplification (RT-MLPA) | mutational analysis | nonmediastinal | MOLECULAR CHARACTERIZATION | SURGERY | CD30 EXPRESSION | D1 EXPRESSION | DIAGNOSIS | TUMOR-SUPPRESSOR GENE | PATHOLOGY | FEATURES | RECURRENT | MYC | HODGKIN LYMPHOMA | MUTATIONS | Genetic aspects | Research | Non-Hodgkin's lymphomas | Gene expression | Copy number variations
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2017, Volume 176, Issue 6, pp. 851 - 866
Summary Peripheral T‐cell lymphoma (PTCL), not otherwise specified (NOS) and angioimmunoblastic T‐cell lymphoma (AITL) are the most frequent of more than 20...
treatment | angioimmunoblastic T‐cell lymphoma | pathology | stem cell transplantation | personalized | Peripheral T‐cell lymphoma | angioimmunoblastic T-cell lymphoma | Peripheral T-cell lymphoma | CTLA4-CD28 GENE FUSION | CD30 EXPRESSION | MULTICENTER PHASE-II | OPEN-LABEL | PREVIOUSLY UNTREATED PATIENTS | ALLOGENEIC TRANSPLANTATION | HIGH-DOSE THERAPY | NON-HODGKIN-LYMPHOMA | LONG-TERM REMISSIONS | DETUDE-DES-LYMPHOMES | HEMATOLOGY | Recurrence | Diagnosis, Differential | Prognosis | Standard of Care | Humans | Drug Resistance, Neoplasm | Treatment Outcome | Practice Patterns, Physicians | Combined Modality Therapy - adverse effects | Molecular Targeted Therapy | Drug Discovery | Immunoblastic Lymphadenopathy - therapy | Immunoblastic Lymphadenopathy - diagnosis | Lymphoma, T-Cell, Peripheral - etiology | Lymphoma, T-Cell, Peripheral - diagnosis | Combined Modality Therapy - methods | Disease Management | Lymphoma, T-Cell, Peripheral - therapy | Neoplasm Staging | Transplantation | Non-Hodgkin's lymphomas | T cells | Stem cells | Drugs | Therapy | Gemcitabine | Stem cell transplantation | Lymphocytes T | Drug delivery | Drug development | Doxorubicin | Immunosuppressive agents | Genetic abnormalities | Salvage | Remission | Autografts | Abnormalities | Etoposide | Prednisone | Patients | Vincristine | Lymphoma | Nitric-oxide synthase | Cyclophosphamide | Lymphomas | Health risk assessment | T-cell lymphoma
treatment | angioimmunoblastic T‐cell lymphoma | pathology | stem cell transplantation | personalized | Peripheral T‐cell lymphoma | angioimmunoblastic T-cell lymphoma | Peripheral T-cell lymphoma | CTLA4-CD28 GENE FUSION | CD30 EXPRESSION | MULTICENTER PHASE-II | OPEN-LABEL | PREVIOUSLY UNTREATED PATIENTS | ALLOGENEIC TRANSPLANTATION | HIGH-DOSE THERAPY | NON-HODGKIN-LYMPHOMA | LONG-TERM REMISSIONS | DETUDE-DES-LYMPHOMES | HEMATOLOGY | Recurrence | Diagnosis, Differential | Prognosis | Standard of Care | Humans | Drug Resistance, Neoplasm | Treatment Outcome | Practice Patterns, Physicians | Combined Modality Therapy - adverse effects | Molecular Targeted Therapy | Drug Discovery | Immunoblastic Lymphadenopathy - therapy | Immunoblastic Lymphadenopathy - diagnosis | Lymphoma, T-Cell, Peripheral - etiology | Lymphoma, T-Cell, Peripheral - diagnosis | Combined Modality Therapy - methods | Disease Management | Lymphoma, T-Cell, Peripheral - therapy | Neoplasm Staging | Transplantation | Non-Hodgkin's lymphomas | T cells | Stem cells | Drugs | Therapy | Gemcitabine | Stem cell transplantation | Lymphocytes T | Drug delivery | Drug development | Doxorubicin | Immunosuppressive agents | Genetic abnormalities | Salvage | Remission | Autografts | Abnormalities | Etoposide | Prednisone | Patients | Vincristine | Lymphoma | Nitric-oxide synthase | Cyclophosphamide | Lymphomas | Health risk assessment | T-cell lymphoma
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 922 - 922
Abstract Introduction. The majority of SMZLs display an indolent course, however the disease is still incurable and a significant proportion of patients...
Journal Article
International journal of surgical pathology, 06/2019, Volume 27, Issue 4, p. 399
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 01/2013, Volume 210, Issue 1, pp. 143 - 156
In the present study, we have investigated the distribution of HIV-specific and HIV-infected CD4 T cells within different populations of memory CD4 T cells...
CXC CHEMOKINE RECEPTOR-5 | VIRAL LOAD | MEDICINE, RESEARCH & EXPERIMENTAL | MEMORY B-CELLS | LYMPHOID-TISSUE | PD-1 BLOCKADE | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNOGLOBULIN PRODUCTION | LATENT RESERVOIR | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | SIV INFECTION | HIV-1 - pathogenicity | Receptors, CXCR5 - metabolism | HIV Infections - virology | Humans | CD4-Positive T-Lymphocytes - metabolism | Programmed Cell Death 1 Receptor - metabolism | DNA, Viral - analysis | Reference Values | Lymph Nodes - virology | Lymph Nodes - immunology | Interleukins - metabolism | T-Lymphocytes, Helper-Inducer - virology | CD4-Positive T-Lymphocytes - immunology | DNA-Binding Proteins - metabolism | HIV Infections - immunology | B-Lymphocytes - immunology | HIV-1 - physiology | Virus Replication | T-Lymphocytes, Helper-Inducer - immunology | B-Lymphocytes - virology | Immunologic Memory | Viremia - immunology | CD4-Positive T-Lymphocytes - virology | Proto-Oncogene Proteins c-bcl-6 | 305 | 302
CXC CHEMOKINE RECEPTOR-5 | VIRAL LOAD | MEDICINE, RESEARCH & EXPERIMENTAL | MEMORY B-CELLS | LYMPHOID-TISSUE | PD-1 BLOCKADE | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNOGLOBULIN PRODUCTION | LATENT RESERVOIR | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | SIV INFECTION | HIV-1 - pathogenicity | Receptors, CXCR5 - metabolism | HIV Infections - virology | Humans | CD4-Positive T-Lymphocytes - metabolism | Programmed Cell Death 1 Receptor - metabolism | DNA, Viral - analysis | Reference Values | Lymph Nodes - virology | Lymph Nodes - immunology | Interleukins - metabolism | T-Lymphocytes, Helper-Inducer - virology | CD4-Positive T-Lymphocytes - immunology | DNA-Binding Proteins - metabolism | HIV Infections - immunology | B-Lymphocytes - immunology | HIV-1 - physiology | Virus Replication | T-Lymphocytes, Helper-Inducer - immunology | B-Lymphocytes - virology | Immunologic Memory | Viremia - immunology | CD4-Positive T-Lymphocytes - virology | Proto-Oncogene Proteins c-bcl-6 | 305 | 302
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.